Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR

LEUKEMIA

NATURE PUBLISHING GROUP

1. NCI NIH HHS [CA18029, R01 CA140371, P01 CA018029-33, P01 CA018029, K23 CA106796, K23 CA106796-04, CA106796] Funding Source: Medline